A.D.A.M. Launches Revolutionary Genetics-Powered Ad Platform
A.D.A.M. Innovations has launched GeneLink in Japan, an advertising platform that blends genetic, lifestyle, and AI-derived insights to target...
No videos found.
FDA Grants Breakthrough Status to Taysha’s Rett Gene Therapy
Taysha Gene Therapies has secured FDA Breakthrough Therapy designation for TSHA-102, an intrathecal AAV9 gene therapy for Rett syndrome,...
AskBio to Present Gene & Cell Therapy Data at ESGCT Meeting
AskBio, a Bayer subsidiary, will deliver one oral and five poster presentations at the European Society of Gene and...
Hutchmed to Present Clinical Data at ESMO Congress 2025
HUTCHMED will bring a dense slate of oncology readouts to ESMO 2025, headlined by phase 3 results from FRUSICA-2...
Silo Pharma Announces Successful $2.5 Million Direct Offering
Silo Pharma has closed a $2.5 million registered direct offering priced at the market under Nasdaq rules, selling 2,857,143...
FDA Grants Promising Orphan Drug Status for Myasthenia Gravis
Cour Pharmaceuticals has secured FDA Orphan Drug Designation for CNP-106, an investigational therapy for anti-acetylcholine receptor antibody–positive generalized myasthenia...
Pharmather’s Ketamine ANDA Sale to Net Over $25 Million
PharmaTher has signed a definitive agreement to sell its FDA-approved ANDA for ketamine hydrochloride injection USP (ANDA #217858) to...
Kura, Kyowa Kirin Launch AML Trial for Dual Gene Mutations
Kura Oncology and Kyowa Kirin have dosed the first patient in a new cohort of the KOMET-007 study assessing...
Surging Aerska Gets $21M for Pioneering RNAi Brain Therapy
Aerska has raised $21 million in seed financing to develop systemically administered RNA interference medicines for neurological diseases, built...
Avalo Therapeutics Expands Leadership with Key Appointments
Avalo Therapeutics has expanded its leadership bench, appointing Taylor Boyd as chief business officer and Ashley Ivanowicz as senior...